The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki, Yingchun Han, Valeria Visconte, Bartlomiej Przychodzen, Claudia M. Espitia, James Phillips, Faiz - Anwer, Anjali Advani, Hetty E. Carraway, Kevin R. Kelly, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalLeukemia
DOIs
StatePublished - Jan 1 2019

Fingerprint

Azacitidine
Autophagy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Nawrocki, S. T., Han, Y., Visconte, V., Przychodzen, B., Espitia, C. M., Phillips, J., ... Carew, J. S. (2019). The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine. Leukemia. https://doi.org/10.1038/s41375-019-0529-2

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine. / Nawrocki, Steffan T.; Han, Yingchun; Visconte, Valeria; Przychodzen, Bartlomiej; Espitia, Claudia M.; Phillips, James; Anwer, Faiz -; Advani, Anjali; Carraway, Hetty E.; Kelly, Kevin R.; Sekeres, Mikkael A.; Maciejewski, Jaroslaw P.; Carew, Jennifer S.

In: Leukemia, 01.01.2019.

Research output: Contribution to journalLetter

Nawrocki, ST, Han, Y, Visconte, V, Przychodzen, B, Espitia, CM, Phillips, J, Anwer, F, Advani, A, Carraway, HE, Kelly, KR, Sekeres, MA, Maciejewski, JP & Carew, JS 2019, 'The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine', Leukemia. https://doi.org/10.1038/s41375-019-0529-2
Nawrocki ST, Han Y, Visconte V, Przychodzen B, Espitia CM, Phillips J et al. The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine. Leukemia. 2019 Jan 1. https://doi.org/10.1038/s41375-019-0529-2
Nawrocki, Steffan T. ; Han, Yingchun ; Visconte, Valeria ; Przychodzen, Bartlomiej ; Espitia, Claudia M. ; Phillips, James ; Anwer, Faiz - ; Advani, Anjali ; Carraway, Hetty E. ; Kelly, Kevin R. ; Sekeres, Mikkael A. ; Maciejewski, Jaroslaw P. ; Carew, Jennifer S. / The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine. In: Leukemia. 2019.
@article{628cacaae6784cbdbb76210c325f805e,
title = "The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine",
author = "Nawrocki, {Steffan T.} and Yingchun Han and Valeria Visconte and Bartlomiej Przychodzen and Espitia, {Claudia M.} and James Phillips and Anwer, {Faiz -} and Anjali Advani and Carraway, {Hetty E.} and Kelly, {Kevin R.} and Sekeres, {Mikkael A.} and Maciejewski, {Jaroslaw P.} and Carew, {Jennifer S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41375-019-0529-2",
language = "English (US)",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

AU - Nawrocki, Steffan T.

AU - Han, Yingchun

AU - Visconte, Valeria

AU - Przychodzen, Bartlomiej

AU - Espitia, Claudia M.

AU - Phillips, James

AU - Anwer, Faiz -

AU - Advani, Anjali

AU - Carraway, Hetty E.

AU - Kelly, Kevin R.

AU - Sekeres, Mikkael A.

AU - Maciejewski, Jaroslaw P.

AU - Carew, Jennifer S.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85069939537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069939537&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0529-2

DO - 10.1038/s41375-019-0529-2

M3 - Letter

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -